257 related articles for article (PubMed ID: 19478948)
1. Selective killing of tumors deficient in methylthioadenosine phosphorylase: a novel strategy.
Lubin M; Lubin A
PLoS One; 2009 May; 4(5):e5735. PubMed ID: 19478948
[TBL] [Abstract][Full Text] [Related]
2. Increasing the therapeutic index of 5-fluorouracil and 6-thioguanine by targeting loss of MTAP in tumor cells.
Tang B; Testa JR; Kruger WD
Cancer Biol Ther; 2012 Sep; 13(11):1082-90. PubMed ID: 22825330
[TBL] [Abstract][Full Text] [Related]
3. Specific Targeting of
Tang B; Lee HO; An SS; Cai KQ; Kruger WD
Cancer Res; 2018 Aug; 78(15):4386-4395. PubMed ID: 29844120
[TBL] [Abstract][Full Text] [Related]
4. Targeting tumors that lack methylthioadenosine phosphorylase (MTAP) activity: current strategies.
Bertino JR; Waud WR; Parker WB; Lubin M
Cancer Biol Ther; 2011 Apr; 11(7):627-32. PubMed ID: 21301207
[TBL] [Abstract][Full Text] [Related]
5. Expression of methylthioadenosine phosphorylase cDNA in p16-, MTAP- malignant cells: restoration of methylthioadenosine phosphorylase-dependent salvage pathways and alterations of sensitivity to inhibitors of purine de novo synthesis.
Chen ZH; Olopade OI; Savarese TM
Mol Pharmacol; 1997 Nov; 52(5):903-11. PubMed ID: 9351982
[TBL] [Abstract][Full Text] [Related]
6. 5'-deoxy-5'-methylthioadenosine phosphorylase--IV. Biological activity of 2-fluoroadenine-substituted 5'-deoxy-5'-methylthioadenosine analogs.
Savarese TM; Cannistra AJ; Parks RE; Secrist JA; Shortnacy AT; Montgomery JA
Biochem Pharmacol; 1987 Jun; 36(12):1881-93. PubMed ID: 3109431
[TBL] [Abstract][Full Text] [Related]
7. Growth and metastases of human lung cancer are inhibited in mouse xenografts by a transition state analogue of 5'-methylthioadenosine phosphorylase.
Basu I; Locker J; Cassera MB; Belbin TJ; Merino EF; Dong X; Hemeon I; Evans GB; Guha C; Schramm VL
J Biol Chem; 2011 Feb; 286(6):4902-11. PubMed ID: 21135097
[TBL] [Abstract][Full Text] [Related]
8. EFA (9-beta-D-erythrofuranosyladenine) is an effective salvage agent for methylthioadenosine phosphorylase-selective therapy of T-cell acute lymphoblastic leukemia with L-alanosine.
Batova A; Cottam H; Yu J; Diccianni MB; Carrera CJ; Yu AL
Blood; 2006 Feb; 107(3):898-903. PubMed ID: 16234352
[TBL] [Abstract][Full Text] [Related]
9. Gene deletion chemoselectivity: codeletion of the genes for p16(INK4), methylthioadenosine phosphorylase, and the alpha- and beta-interferons in human pancreatic cell carcinoma lines and its implications for chemotherapy.
Chen ZH; Zhang H; Savarese TM
Cancer Res; 1996 Mar; 56(5):1083-90. PubMed ID: 8640765
[TBL] [Abstract][Full Text] [Related]
10. 5'-deoxy-5'-methylthioadenosine phosphorylase--II. Role of the enzyme in the metabolism and antineoplastic action of adenine-substituted analogs of 5'-deoxy-5'-methylthioadenosine.
Savarese TM; Dexter DL; Parks RE
Biochem Pharmacol; 1983 Jun; 32(12):1907-16. PubMed ID: 6411095
[TBL] [Abstract][Full Text] [Related]
11. 6-thioguanine: a drug with unrealized potential for cancer therapy.
Munshi PN; Lubin M; Bertino JR
Oncologist; 2014 Jul; 19(7):760-5. PubMed ID: 24928612
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of methylthioadenosine phosphorylase (MTAP) induces progression of hepatocellular carcinoma via accumulation of 5'-deoxy-5'-methylthioadenosine (MTA).
Kirovski G; Stevens AP; Czech B; Dettmer K; Weiss TS; Wild P; Hartmann A; Bosserhoff AK; Oefner PJ; Hellerbrand C
Am J Pathol; 2011 Mar; 178(3):1145-52. PubMed ID: 21356366
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of purines in human lymphoblast cells deficient in methylthioadenosine phosphorylase activity.
Gordon RB; Blackwell K; Emmerson BT
Biochim Biophys Acta; 1987 Jan; 927(1):1-7. PubMed ID: 3098299
[TBL] [Abstract][Full Text] [Related]
14. Increased sensitivity to thiopurines in methylthioadenosine phosphorylase-deleted cancers.
Coulthard SA; Redfern CP; Vikingsson S; Lindqvist-Appell M; Skoglund K; Jakobsen-Falk I; Hall AG; Taylor GA; Hogarth LA
Mol Cancer Ther; 2011 Mar; 10(3):495-504. PubMed ID: 21282358
[TBL] [Abstract][Full Text] [Related]
15. Disordered methionine metabolism in MTAP/CDKN2A-deleted cancers leads to dependence on PRMT5.
Mavrakis KJ; McDonald ER; Schlabach MR; Billy E; Hoffman GR; deWeck A; Ruddy DA; Venkatesan K; Yu J; McAllister G; Stump M; deBeaumont R; Ho S; Yue Y; Liu Y; Yan-Neale Y; Yang G; Lin F; Yin H; Gao H; Kipp DR; Zhao S; McNamara JT; Sprague ER; Zheng B; Lin Y; Cho YS; Gu J; Crawford K; Ciccone D; Vitari AC; Lai A; Capka V; Hurov K; Porter JA; Tallarico J; Mickanin C; Lees E; Pagliarini R; Keen N; Schmelzle T; Hofmann F; Stegmeier F; Sellers WR
Science; 2016 Mar; 351(6278):1208-13. PubMed ID: 26912361
[TBL] [Abstract][Full Text] [Related]
16. Presence of methylthioadenosine phosphorylase (MTAP) in hematopoietic stem/progenitor cells: its therapeutic implication for MTAP (-) malignancies.
Yu J; Batova A; Shao L; Carrera CJ; Yu AL
Clin Cancer Res; 1997 Mar; 3(3):433-8. PubMed ID: 9815702
[TBL] [Abstract][Full Text] [Related]
17. Lack of expression of MTAP in uncommon T-cell lymphomas.
Bertino JR; Lubin M; Johnson-Farley N; Chan WC; Goodell L; Bhagavathi S
Clin Lymphoma Myeloma Leuk; 2012 Oct; 12(5):306-9. PubMed ID: 23040436
[TBL] [Abstract][Full Text] [Related]
18. Homozygous MTAP deletion in primary human glioblastoma is not associated with elevation of methylthioadenosine.
Barekatain Y; Ackroyd JJ; Yan VC; Khadka S; Wang L; Chen KC; Poral AH; Tran T; Georgiou DK; Arthur K; Lin YH; Satani N; Ballato ES; Behr EI; deCarvalho AC; Verhaak RGW; de Groot J; Huse JT; Asara JM; Kalluri R; Muller FL
Nat Commun; 2021 Jul; 12(1):4228. PubMed ID: 34244484
[TBL] [Abstract][Full Text] [Related]
19. MTAP deletion confers enhanced dependency on the PRMT5 arginine methyltransferase in cancer cells.
Kryukov GV; Wilson FH; Ruth JR; Paulk J; Tsherniak A; Marlow SE; Vazquez F; Weir BA; Fitzgerald ME; Tanaka M; Bielski CM; Scott JM; Dennis C; Cowley GS; Boehm JS; Root DE; Golub TR; Clish CB; Bradner JE; Hahn WC; Garraway LA
Science; 2016 Mar; 351(6278):1214-8. PubMed ID: 26912360
[TBL] [Abstract][Full Text] [Related]
20. MTAP gene deletion in endometrial cancer.
Wong YF; Chung TK; Cheung TH; Nobori T; Chang AM
Gynecol Obstet Invest; 1998; 45(4):272-6. PubMed ID: 9623796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
